Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion
Craig Wong-Pan

Craig Wong-Pan Analyst Performance

Director and Equity Research Analyst at Royal Bank Of Canada

Craig Wong-Pan is a stock analyst at Royal Bank Of Canada in the medical sector, covering 1 publicly traded companies. Over the past year, Craig Wong-Pan has issued 5 stock ratings, including and buy recommendations. While full access to Craig Wong-Pan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Craig Wong-Pan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
11 Last 4 Years
Buy Recommendations
45.45% 5 Buy Ratings
Companies Covered
1 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy45.5%5 ratings
Hold27.3%3 ratings
Sell27.3%3 ratings

Out of 11 total stock ratings issued by Craig Wong-Pan at Royal Bank Of Canada, the majority (45.5%) have been Buy recommendations, followed by 27.3% Hold and 27.3% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
100.0% of companies on NYSE
1 company

Craig Wong-Pan, an analyst at Royal Bank Of Canada, currently covers 1 companies listed on , with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
100.0%

Craig Wong-Pan of Royal Bank Of Canada specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED PRODUCTS
1 company
100.0%

About Craig Wong-Pan

Craig Wong-Pan joined RBC Capital Markets in 2021, and covers the Australian Healthcare and MedTech sectors. Prior to joining RBC, Craig worked at CLSA and prior to that spent 12 years at Deutsche Bank, where he covered the Healthcare, Technology, Online Media, Telecommunications and Contractors sectors. Craig started his career as an auditor at EY, before transferring to the firm’s Valuations & Financial Modelling team. Craig graduated with a Bachelor of Accounting from the University of Technology Sydney, and qualified as a Chartered Accountant during his time at EY.
Follow on LinkedIn

Craig Wong-Pan's Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
ResMed Inc. stock logo
RMD
ResMed
5/1/2026Boost Price Target$203.34$321.00Outperform
ResMed Inc. stock logo
RMD
ResMed
1/30/2026Boost Price Target$257.83$314.00Outperform
ResMed Inc. stock logo
RMD
ResMed
10/31/2025Boost Price Target$244.60$303.00Outperform
ResMed Inc. stock logo
RMD
ResMed
8/1/2025Boost Price Target$279.57$300.00Outperform
ResMed Inc. stock logo
RMD
ResMed
7/15/2025Upgrade$254.09$294.00Outperform
ResMed Inc. stock logo
RMD
ResMed
4/24/2025Boost Price Target$239.13$255.00Sector Perform